As of 13 July 2021, BNP Paribas received the necessary approvals and acquired 100% of Exane, raising its stake from the 50% previously held during a successful 17-year partnership. This transaction will further strengthen and widen the range of cash equities (execution and research) and derivatives services BNP Paribas can offer to institutional investors and corporates globally.
BNP Paribas Corporate and Institutional Banking (CIB) is a globally recognised leader offering tailored financial solutions for corporate and institutional clients, including capital markets issuance, securities services, financing, treasury, advisory solutions, risk management and hedging. By matching the financing needs of companies with the investment opportunities sought by institutional investors, BNP Paribas CIB’s financial solutions create value while contributing to the financing of the economy. Click here for more information about BNP Paribas CIB.
Note: BNP Paribas and Exane are working closely towards a seamless and smooth transition, which includes the sharing of certain client information, in line with each entity’s regulatory requirements.
CASH EQUITIES
BNP Paribas Exane, Cash Equities provides institutional investors with a full range of Execution, Research, Sales, and Corporate Access services.
STRUCTURED SOLUTIONS
Exane Solutions has developed a complete range of products and services for asset managers, wealth managers, and private bankers.
ASSET MANAGEMENT
Exane’s asset management business is built around its asset management company Exane Asset Management.